Yu-feng F. Wei
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications
Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular outcomes in chronic obstructive pulmonary disease: A systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials.
Journal: The Journal of international medical research
Published: May 31, 2026
Clinical manifestations of Mycobacterium abscessus lung disease according to different morphotypes.
Journal: Journal of global health
Published: May 22, 2026
Using droplet digital polymerase chain reaction for cell-free DNA to diagnose tuberculous pleural effusion.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 12, 2026
Correction: Comparing survival outcomes of anti-fibrotic therapy for idiopathic pulmonary fibrosis with and without emphysema: a multi-center real-world study from Taiwan.
Journal: BMC pulmonary medicine
Published: October 28, 2025
Real-World Effectiveness and Safety of Immune Checkpoint Inhibitors Combined with Chemotherapy in Taiwanese Patients with Extensive-Stage Small Cell Lung Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: July 22, 2025
Clinical features and outcomes of first-line EGFR-TKI treatment in younger and older patients with EGFR-mutated NSCLC.
Journal: Future oncology (London, England)
Published: June 08, 2025
Comparing survival outcomes of anti-fibrotic therapy for idiopathic pulmonary fibrosis with and without emphysema: a multi-center real-world study from Taiwan.
Journal: BMC pulmonary medicine
Published: April 25, 2025
Cardiovascular disease as a prognostic factor for mortality in non-cystic fibrosis bronchiectasis: data from the Taiwan Bronchiectasis Research Collaboration.
Journal: ERJ open research
Published: March 04, 2025
Unraveling Survival Determinants in Patients with Advanced Non-Small-Cell Lung Cancer with EGFR Exon 20 Insertions.
Journal: Current oncology (Toronto, Ont.)
Published: February 02, 2025
A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT).
Journal: Therapeutic advances in respiratory disease
Published: January 20, 2025
Impact of Subsequent Treatment on Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Transformed to Small-Cell Lung Cancer.
Journal: Lung Cancer (Auckland, N.Z.)
Published: January 09, 2025
Last Updated: 09/26/2026